The IMCD Group has acquired all shares of Jan Dekker International, a distributor of personal care and food ingredients. Headquartered in Wormerveer in The Netherlands, Jan Dekker has 64 staff and sales offices in France, Germany, Poland, UK and Spain. In addition, it runs two laboratories, one in The Netherlands and one in France. The deal is effective immediately.
The Pharmaceutical & Cosmetic Review/IFF New Product Competition has gone 
global, expanding the prestige and significance that your winning product will receive.
If you believe that your product is ground-breaking, then you can’t afford not to parade it among its peers in the upcoming P&C Review/IFF New Product Competition (NPC). And luckily, there’s still time to enter as the deadline has been extended until 25 May 2012.
Now in it’s 5th year, the lauded event just gets better and better, and the quantity and quality of the entries is something to crow about. Previously, the NPC was only open to South African manufacturers, but in 2011, it was extended to include international brands too.
Oat Cosmetics has launched an Ecocert accredited CP Sweet Blue Lupin 
Peptide, which has been shown to retain hair colour-fastness for 30 washes and is equivalent in performance to many synthetic products.
In addition, tests show that the peptides coat and penetrate the hair shaft in one application, resulting in increased strength, less breakage through brushing and virtually no build up.
Evocutis, which conducts advanced laboratory and clinical evaluations of skin care products for the health and cosmetic markets, has launched a highly-defined panel of 36 strains of Propionibacterium acnes (P. acnes) to improve the reliability of testing undertaken during anti‐acne or anti‐spot product research and development.
The testing of anti‐acne and blemish‐reduction products for antimicrobial activity against P.
acnes is a recognised method for determining potential efficacy, but is usually performed against a single strain. With a robust panel of clinically relevant strains, Evocutis can now offer health care and pharmaceutical companies developing anti‐acne and anti‐spot ingredients or products a more reliable R&D selection tool. The panel includes strains resistant to antibiotics commonly used in treating acne, thus indicating whether test materials would be able to help reduce the prevalence of antibiotic resistance.
The US Food a
nd Drug Administration (FDA) will continue to evaluate the levels of lead found in lipsticks to ensure it protects the health of consumers, having completed its latest analysis on 400 lipsticks at the end of last year.
Although cosmetic safety activists such as The Campaign For Safe Cosmetics applied pressure to the agency after the study found lead in 400 lipsticks tested at widely varying levels of up to 7.19 parts per million (ppm), the Personal Care Products Council (PCPC) has come out in defense of the industry.
PCPC chief scientist Halyna Breslawec said: 'The FDA again has reviewed the lead levels found in lipstick and determined them to be safe.'
Local nail care brand, Tip
Top, will be launching sixty new lacquer shades into 50 selected Foschini stores.
The collection includes 60 catwalk-inspired colours, which are quick-drying, streak-free and give a high-shine finish for several days. Continuing with the brand's tradition, all the new colours have creative names emphasising the fun vibe behind the range such as the I LUV DENIM duo of light and dark shimmering blue and the U CRACK ME UP Crackle line.
This line has also been expanded with the addition of two new shades: silver and white.
A wide selection of Windrose oils’ quality aromatherapy products are now being listed at Dis-Chem Pharmacies, making the popular products more readily accessible to general shoppers, beauty therapists and students, than before. ‘We are delighted [ ... ]
On May 1, 212, the FDA approved Protalix BioTherapeutic’s Elelyso (taliglucerase alfa), a new enzyme replacement therapy (ERT) that provides patients with Gaucher disease an alternative therapeutic option to Genzyme’s Cerezyme (imiglucerase), th [ ... ]
The emerging countries of Brazil, Russia, India and China (BRIC) represent a promising region for the diagnostic testing industry, as population growth and unhealthy lifestyles mean the patient population is growing rapidly, according to a new report [ ... ]
IMAP, a provider of premium M&A services worldwide, released its Global Pharma and Biotech M&A Report 212 today. The report includes a dedicated section on China’s rapidly growing Pharma market. In 211, the pharmaceutical industry saw 5 [ ... ]
A draft of the long-awaited regulations defining the difference between health insurance policies, including products like gap cover, and medical schemes, along with the various jurisdictions of each, was released on Friday 2 April 212.
